Log in

Relevant bibliographies by topics / Progression / Journal articles

To see the other types of publications on this topic, follow the link: Progression.

Journal articles on the topic 'Progression'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Progression.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Arena, Julieta E., Stephen D. Weigand, Jennifer L. Whitwell, et al. "Progressive supranuclear palsy: progression and survival." Journal of Neurology 263, no. 2 (2015): 380–89. http://dx.doi.org/10.1007/s00415-015-7990-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Hartmann, J. T., F. Heidel, J. Stoehlmacher, et al. "Pattern of progression and its impact on outcome in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: A retrospective multicenter long-term follow-up study." Journal of Clinical Oncology 24, no. 18_suppl (2006): 9541. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9541.

Full text

Abstract:

9541 Background: To investigate the clinical impact of the different types of disease progression (focal v extensive) in patients (pts) with metastatic gastrointestinal stromal tumors (GIST) after initial response to imatinib. Methods: Pts who received imatinib for metastatic GIST at three Cancer Centers and who have been followed up for at least 2.5 years were eligible for the study. Disease progression was classified as focal or extensive as defined by protocol. Responses were evaluated according to WHO criteria. Progression-free survival (PFS) and overall survival (OS) were calculated accor

APA, Harvard, Vancouver, ISO, and other styles

3

Wilson, Mark. "Measuring progressions: Assessment structures underlying a learning progression." Journal of Research in Science Teaching 46, no. 6 (2009): 716–30. http://dx.doi.org/10.1002/tea.20318.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Plotkin, Daniel, Max Coleman, Derrick Van Every, et al. "Progressive overload without progressing load? The effects of load or repetition progression on muscular adaptations." PeerJ 10 (September 30, 2022): e14142. http://dx.doi.org/10.7717/peerj.14142.

Full text

Abstract:

Background Progressive overload is a principle of resistance training exercise program design that typically relies on increasing load to increase neuromuscular demand to facilitate further adaptations. However, little attention has been given to another way of increasing demand—increasing the number of repetitions. Objective This study aimed to compare the effects of two resistance training programs: (1) increasing load while keeping repetition range constant vs (2) increasing repetitions while keeping load constant. We aimed to compare the effects of these programs on lower body muscle hyper

APA, Harvard, Vancouver, ISO, and other styles

5

Bhavana S, Junagade, and Sabnis Anjali S. "Schizencephaly: A Neuronal Progression Disorder." Indian Journal of Anatomy 7, no. 2 (2018): 215–17. http://dx.doi.org/10.21088/ija.2320.0022.7218.19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Malpetti, Maura, Luca Passamonti, Peter Simon Jones, et al. "Neuroinflammation predicts disease progression in progressive supranuclear palsy." Journal of Neurology, Neurosurgery & Psychiatry 92, no. 7 (2021): 769–75. http://dx.doi.org/10.1136/jnnp-2020-325549.

Full text

Abstract:

IntroductionIn addition to tau pathology and neuronal loss, neuroinflammation occurs in progressive supranuclear palsy (PSP). However, the prognostic value of the in vivo imaging markers for these processes in PSP remains unclear. We test the primary hypothesis that baseline in vivo imaging assessment of neuroinflammation in subcortical regions predicts clinical progression in patients with PSP.MethodsSeventeen patients with PSP–Richardson’s syndrome underwent a baseline multimodal imaging assessment, including [11C]PK11195 positron emission tomography (PET) to index microglial activation, [18

APA, Harvard, Vancouver, ISO, and other styles

7

Bogucki, Andrzej, Justyna Pigońska, Iwona Szadkowska, and Agata Gajos. "Unilateral progressive muscular atrophy with fast symptoms progression." Neurologia i Neurochirurgia Polska 50, no. 1 (2016): 52–54. http://dx.doi.org/10.1016/j.pjnns.2015.10.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Gil‐Perotin, Sara, Carmen Alcalá, Francisco Carlos Pérez‐Miralles, and Bonaventura Casanova. "Silent Progression or Bout Onset Progressive Multiple Sclerosis?" Annals of Neurology 86, no. 3 (2019): 472. http://dx.doi.org/10.1002/ana.25537.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Krug, Hollis E., Maren L. Mahowald, Paul B. Halverson, John D. Sallis, and Herman S. Cheung. "Phosphocitrate prevents disease progression in murine progressive ankylosis." Arthritis & Rheumatism 36, no. 11 (1993): 1603–11. http://dx.doi.org/10.1002/art.1780361116.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Whitwell, Jennifer L., Jia Xu, Jay Mandrekar, Jeffrey L. Gunter, Clifford R. Jack, and Keith A. Josephs. "Imaging measures predict progression in progressive supranuclear palsy." Movement Disorders 27, no. 14 (2012): 1801–4. http://dx.doi.org/10.1002/mds.24970.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Dickerson, Bradford C. "Quantitating Severity and Progression in Primary Progressive Aphasia." Journal of Molecular Neuroscience 45, no. 3 (2011): 618–28. http://dx.doi.org/10.1007/s12031-011-9534-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pugh, Siân A., Megan Bowers, Alexandre Ball, et al. "Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study." British Journal of Cancer 115, no. 4 (2016): 420–24. http://dx.doi.org/10.1038/bjc.2016.208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Jeyapalan, Suriya A., Steven A. Toms, Andreas Felix Hottinger, et al. "Analysis of the EF-14 phase III trial reveals that tumor treating fields alter progression patterns in glioblastoma." Journal of Clinical Oncology 37, no. 15_suppl (2019): 2055. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.2055.

Full text

Abstract:

2055 Background: The EF-14 [NCT00916409] trial showed that addition of alternating electric fields (Tumor Treating Fields, TTFields) to Temozolomide (TMZ) resulted in improved survival in newly diagnosed Glioblastoma (GBM) patients with supratentorial tumors treated compared to TMZ alone. TTFields delivery is planned to optimize dose at the tumor bed, leading to the hypothesis that TTFields treated patients are more likely to exhibit distal progressions, including progression to the infratentorial brain where TTFields dose is minimal when targeting the supratentorium. Here we present analysis

APA, Harvard, Vancouver, ISO, and other styles

14

Kim, Chul, Nitin Roper, Chuong D. Hoang, et al. "Local ablative therapy (LAT) for oligoprogressive, EGFR-mutant, non-small cell lung cancer (NSCLC) after treatment with osimertinib." Journal of Clinical Oncology 35, no. 15_suppl (2017): e20545-e20545. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e20545.

Full text

Abstract:

e20545 Background: EGFR tyrosine kinase inhibitors (EGFR-TKIs) improve progression-free survival (PFS) in patients with EGFR-mutant NSCLC, but disease progression limits efficacy. Retrospective studies show a survival benefit to LAT in patients with oligoprogressive disease (progression at a limited number of anatomic sites). Methods: This is a prospective study of LAT in patients with oligoprogressive EGFR-mutant NSCLC. Patients with no prior EGFR-TKI therapy (cohort 1) or progression after 1st/2ndgeneration EGFR-TKIs with acquired T790M mutation (cohort 2) receive osimertinib. Upon progressi

APA, Harvard, Vancouver, ISO, and other styles

15

Bovenzi, Matthew D., Jerome Sherman, and Sherry J. Bass. "Schnelle Progression zur poliferativen diabetischen Retinopathie." Optometry & Contact Lenses 2, no. 1 (2021): 28–36. http://dx.doi.org/10.54352/dozv.pxzz4986.

Full text

Abstract:

Purpose. This case report illustrates rapid progression of diabetic retinopathy in a patient with poor compliance to diabetic management. It additionally demonstrates the utility of panoramic/ultra-wide field retinal imaging in assessing diabetic retinopathy progression. Material and Methods. A 42-year-old female patient was examined seven times over a 25 month period at a private ophthalmology/optometry practice with dilated fundus examinations. Fundus images were obtained using a pano- ramic/ultra-widefield laser retinal imager. Fluorescein angio- graphy (FA) was performed to assess for diab

APA, Harvard, Vancouver, ISO, and other styles

16

Phadke, Aryan. "Approximation of Sum of Harmonic Progression." International Journal of Science and Research (IJSR) 13, no. 1 (2024): 1101–7. http://dx.doi.org/10.21275/sr24115160243.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Nath, A., A. Venkataramana, D. S. Reich, I. Cortese, and E. O. Major. "Progression of progressive multifocal leukoencephalopathy despite treatment with -interferon." Neurology 66, no. 1 (2006): 149–50. http://dx.doi.org/10.1212/01.wnl.0000191322.93310.a1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Skromne, E., V. M. Rivera, D. Ontaneda, et al. "Progression of progressive multifocal leukoencephalopathy despite treatment with -interferon." Neurology 66, no. 11 (2006): 1787–88. http://dx.doi.org/10.1212/01.wnl.0000230563.29202.6a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Lysén, M. "Progression." Pleiades: Literature in Context 36, no. 1 (2016): 41. http://dx.doi.org/10.1353/plc.2016.0049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Hinchman, Kathleen A., and Kelly Chandler‐Olcott. "Progression." Journal of Adolescent & Adult Literacy 63, no. 4 (2019): 369–70. http://dx.doi.org/10.1002/jaal.1036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Sanna, Carlo. "Covering an arithmetic progression with geometric progressions and vice versa." International Journal of Number Theory 10, no. 06 (2014): 1577–82. http://dx.doi.org/10.1142/s1793042114500456.

Full text

Abstract:

We show that there exists a positive constant C such that the following holds: Given an infinite arithmetic progression [Formula: see text] of real numbers and a sufficiently large integer n (depending on [Formula: see text]), there is a need of at least Cn geometric progressions to cover the first n terms of [Formula: see text]. A similar result is presented, with the role of arithmetic and geometric progressions reversed.

APA, Harvard, Vancouver, ISO, and other styles

22

Sim, Kai An, and Kok Bin Wong. "Magic Square and Arrangement of Consecutive Integers That Avoids k-Term Arithmetic Progressions." Mathematics 9, no. 18 (2021): 2259. http://dx.doi.org/10.3390/math9182259.

Full text

Abstract:

In 1977, Davis et al., proposed a method to generate an arrangement of [n]={1,2,…,n} that avoids three-term monotone arithmetic progressions. Consequently, this arrangement avoids k-term monotone arithmetic progressions in [n] for k≥3. Hence, we are interested in finding an arrangement of [n] that avoids k-term monotone arithmetic progression, but allows k−1-term monotone arithmetic progression. In this paper, we propose a method to rearrange the rows of a magic square of order 2k−3 and show that this arrangement does not contain a k-term monotone arithmetic progression. Consequently, we show

APA, Harvard, Vancouver, ISO, and other styles

23

Bancin, Martin, Andi Wete Polili, and Nurilam Harianja. "ANALYSE DE PROGRESSION THEMATIQUE LINÉAIRE DANS LE TEXTE DESCRIPTIF." HEXAGONE Jurnal Pendidikan, Linguistik, Budaya dan Sastra Perancis 5, no. 1 (2016): 92. http://dx.doi.org/10.24114/hxg.v5i1.3915.

Full text

Abstract:

RÉSUMÉ Le but de cette recherche est pour trouver les progressions thématiques utilisées dans le journal Le Monde surtout la progression thématique linéaire. En les trouvant, cette recherche a pour but aussi de trouver les formes de progression linéaire. La méthode de la recherche est la méthode qualitative. La méthode qualitative est un procès de la recherche qui produit la donnée descriptive comme le mot à l’écrit ou à l’oral des personnes observées. Cette méthode de recherche va expliquer une condition de vérité et donner la priorité à la donnée que la théorie. Pour analyser les données, l’

APA, Harvard, Vancouver, ISO, and other styles

24

M.G.S., Dilanthi. "Empirical Progression of Lean Manufacturing: Literature Review." International Journal of Engineering Research 3, no. 11 (2014): 657–61. http://dx.doi.org/10.17950/ijer/v3s11/1107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

ThinkaKamara, Emmanuel. "Deviation for Numbers in An Arithmetic Progression." International Journal of Science and Research (IJSR) 13, no. 3 (2024): 1111–12. http://dx.doi.org/10.21275/es24301151237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

O'Connor, Paul. "Interferon-β1b reduced the progression of secondary progressive multiple sclerosis". ACP Journal Club 130, № 3 (1999): 69. http://dx.doi.org/10.7326/acpjc-1999-130-3-069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Caffarra, Paolo, Simona Gardini, Stefano Cappa, et al. "Degenerative Jargon Aphasia: Unusual Progression of Logopenic/Phonological Progressive Aphasia?" Behavioural Neurology 26, no. 1-2 (2013): 89–93. http://dx.doi.org/10.1155/2013/965782.

Full text

Abstract:

Primary progressive aphasia (PPA) corresponds to the gradual degeneration of language which can occur as nonfluent/agrammatic PPA, semantic variant PPA or logopenic variant PPA. We describe the clinical evolution of a patient with PPA presenting jargon aphasia as a late feature. At the onset of the disease (ten years ago) the patient showed anomia and executive deficits, followed later on by phonemic paraphasias and neologisms, deficits in verbal short-term memory, naming, verbal and semantic fluency. At recent follow-up the patient developed an unintelligible jargon with both semantic and neo

APA, Harvard, Vancouver, ISO, and other styles

28

Haley, E. C., N. F. Kassell, and J. C. Torner. "Failure of heparin to prevent progression in progressing ischemic infarction." Stroke 19, no. 1 (1988): 10–14. http://dx.doi.org/10.1161/01.str.19.1.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Robinson, Richard. "What New Understanding of Progressive MS Reveals About Disease Progression." Neurology Today 19, no. 12 (2019): 25–26. http://dx.doi.org/10.1097/01.nt.0000569664.72043.62.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Marrodan, M., C. Bensi, A. Pappolla, et al. "Disease activity impacts disability progression in primary progressive multiple sclerosis." Multiple Sclerosis and Related Disorders 39 (April 2020): 101892. http://dx.doi.org/10.1016/j.msard.2019.101892.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Kosa, Peter, Tianxia Wu, Jonathan Phillips, et al. "Idebenone does not inhibit disability progression in primary progressive MS." Multiple Sclerosis and Related Disorders 45 (October 2020): 102434. http://dx.doi.org/10.1016/j.msard.2020.102434.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Gao, Hui-Ming, and Jau-Shyong Hong. "Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression." Trends in Immunology 29, no. 8 (2008): 357–65. http://dx.doi.org/10.1016/j.it.2008.05.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Jabbari, Edwin, John Woodside, and Huw Morris. "PO082 Can csf nfl predict progression in progressive supranuclear palsy?" Journal of Neurology, Neurosurgery & Psychiatry 88, Suppl 1 (2017): A33.1—A33. http://dx.doi.org/10.1136/jnnp-2017-abn.113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Cree, Bruce A. C., and Stephen L. Hauser. "Reply to “Silent Progression or Bout Onset Progressive Multiple Sclerosis?”." Annals of Neurology 86, no. 3 (2019): 472–73. http://dx.doi.org/10.1002/ana.25536.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Rojas, Julio C., Anna Karydas, Jee Bang, et al. "Plasma neurofilament light chain predicts progression in progressive supranuclear palsy." Annals of Clinical and Translational Neurology 3, no. 3 (2016): 216–25. http://dx.doi.org/10.1002/acn3.290.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Sudha, AndeJeevana, Chaturbhuj Rathore, Sunil Kumar, and Gowtham Yeeli. "Rapidly progressive dementia: Clue lies in the speed of progression." Journal of Integrated Health Sciences 9, no. 2 (2021): 125. http://dx.doi.org/10.4103/jihs.jihs_20_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Koc, G. H., M. R. Kok, J. Luime, et al. "OP0065 THE DETERMINANTS OF RADIOGRAPHIC PROGRESSION IN EARLY PSA PATIENTS." Annals of the Rheumatic Diseases 82, Suppl 1 (2023): 44.2–45. http://dx.doi.org/10.1136/annrheumdis-2023-eular.5638.

Full text

Abstract:

BackgroundPsoriatic arthritis (PsA) is inflammatory arthritis associated with a progressive erosive disease which had been reported in more than one-half of patients with PsA and is often associated with functional impairment [1]. Despite advances in diagnosis and therapy, radiographic structural damage is still prevalent in PsA. To shed light on this topic, we studied which clinical characteristics determine radiographic progression using conventional radiography.ObjectivesOur aim is to assess baseline clinical parameters as determinants for radiographic progression in early PsA patients at 2

APA, Harvard, Vancouver, ISO, and other styles

38

Liao, Jianling. "Do learners use different topical progression patterns in L2 Chinese argumentative spoken and written discourse?" Chinese as a Second Language Research 12, no. 1 (2023): 37–64. http://dx.doi.org/10.1515/caslar-2023-0002.

Full text

Abstract:

Abstract The current study examines how L2 Chinese learners develop their topics in spoken and written discourse. Currently, researchers have mainly analyzed topical progression features in written texts. Topical progression in speech is rarely examined. We know little about whether learners may advance their topics differently in spoken and written discourse. The current study investigates how advanced Chinese learners apply topical progressions, such as parallel or sequential progression, in argumentative spoken and written discourse, respectively. The study also examines how various topical

APA, Harvard, Vancouver, ISO, and other styles

39

Pagano, Gennaro, Kirsten I. Taylor, Judith Anzures Cabrera, et al. "Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease." Nature Medicine 30, no. 4 (2024): 1096–103. http://dx.doi.org/10.1038/s41591-024-02886-y.

Full text

Abstract:

AbstractPrasinezumab, a monoclonal antibody that binds aggregated α-synuclein, is being investigated as a potential disease-modifying therapy in early-stage Parkinson’s disease. Although in the PASADENA phase 2 study, the primary endpoint (Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) sum of Parts I + II + III) was not met, prasinezumab-treated individuals exhibited slower progression of motor signs than placebo-treated participants (MDS-UPDRS Part III). We report here an exploratory analysis assessing whether prasinezumab showed greater benefits on motor signs

APA, Harvard, Vancouver, ISO, and other styles

40

Boehling, Nicholas S., David R. Grosshans, Pamela K. Allen, et al. "Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases." Journal of Neurosurgery: Spine 16, no. 4 (2012): 379–86. http://dx.doi.org/10.3171/2011.11.spine116.

Full text

Abstract:

Object The aim of this study was to identify potential risk factors for and determine the rate of vertebral compression fracture (VCF) after intensity-modulated, near-simultaneous, CT image–guided stereotactic body radiotherapy (SBRT) for spinal metastases. Methods The study group consisted of 123 vertebral bodies (VBs) in 93 patients enrolled in prospective protocols for metastatic disease. Data from these patients were retrospectively analyzed. Stereotactic body radiotherapy consisted of 1, 3, or 5 fractions for overall median doses of 18, 27, and 30 Gy, respectively. Magnetic resonance imag

APA, Harvard, Vancouver, ISO, and other styles

41

J. Kramer, Holly, and Sankar D. Navaneethan. "CKD Progression." Nephrology Self-Assessment Program 18, no. 4 (2019): 202–9. http://dx.doi.org/10.1681/nsap.2019.18.4.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Joudan, Shira. "Postdoc progression." Nature Chemistry 14, no. 10 (2022): 1089–90. http://dx.doi.org/10.1038/s41557-022-01053-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Bridges, Glenys. "Optimising progression." Dental Nursing 18, no. 3 (2022): 116–19. http://dx.doi.org/10.12968/denn.2022.18.3.116.

Full text

Abstract:

Glenys Bridges discusses proactive CPD choices for dental nurses with extended duties Aims To define CPD requirements for dental nurses performing extended duties. To identify the implications of GDC Principle 7.2 on dental nurse development. Objectives To be able to recognise a range of proactive development opportunities for dental nurses. To be able to make informed choices to select CPD programmes that progress confidence and competence. To be able to select CPD opportunities that reflect ongoing learning needs. To be able to use record-keeping, peer review and reflective practice to imple

APA, Harvard, Vancouver, ISO, and other styles

44

Benner, Steven A. "Natural progression." Nature 409, no. 6819 (2001): 459. http://dx.doi.org/10.1038/35054149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Martinez-Conde, Susana. "Age progression." Nature 527, no. 7578 (2015): 404. http://dx.doi.org/10.1038/527404a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Rosneck, James S., Donna Waechter, Donald A. Noe, and Richard Josephson. "EXERCISE PROGRESSION." Journal of Cardiopulmonary Rehabilitation and Prevention 27, no. 5 (2007): 337. http://dx.doi.org/10.1097/01.hcr.0000291359.16946.54.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Elder, David E. "Melanoma progression." Pathology 48, no. 2 (2016): 147–54. http://dx.doi.org/10.1016/j.pathol.2015.12.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Calabrese, Peter, Simon Tavaré, and Darryl Shibata. "Pretumor Progression." American Journal of Pathology 164, no. 4 (2004): 1337–46. http://dx.doi.org/10.1016/s0002-9440(10)63220-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Einecke, Dirk. "Progression gebremst." MMW - Fortschritte der Medizin 156, no. 21-22 (2014): 100. http://dx.doi.org/10.1007/s15006-014-3834-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Swami, Meera. "Monitoring progression." Nature Reviews Cancer 9, no. 4 (2009): 229. http://dx.doi.org/10.1038/nrc2630.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!